AKRFF yields 2063.98% · JNJ yields 2.13%● Live data
📍 AKRFF pulled ahead of the other in Year 1
Combined, AKRFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AKRFF + JNJ for your $10,000?
Ackroo Inc. develops and sells an online loyalty and rewards platform that enables businesses to design and execute customer transaction, engagement, and retention strategies primarily in North America. It enables small to medium sized businesses to automate the processing and management of gift card and loyalty transactions to increase profitability and build long-term customer relationships. The company's cloud-based marketing platform provides merchants an in-store and online process to manage loyalty, gift card, and promotional transactions at the point of sale; a program to help them view data for reconciliation, reporting, and marketing; and customer interfaces to allow merchant's consumers to register, check, transfer, and reload balances. It also provides AckrooPOS/GGGolf platform for golf clubs, which integrates accounting and hospitality point of sale options and other services; and offers handicapping services, as well as to manage tee-sheets, lottery, and tournaments. In addition, the company offers marketing services, including email and direct mail marketing, and design services; and payment services comprising credit and debit card processing services. It serves automotive, petroleum, hospitality, and retail markets. Ackroo Inc. was founded in 2012 and is headquartered in Hamilton, Canada.
Full AKRFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.